Egor Melnikov, Founder of ARNA Genomics US Inc., was honored by CEO Today Magazine with a 2021 CEO Global award for scientific research and business results achieved over the last 12 months. The magazine recognizes those CEOs who have disrupted the industry’s status quo and taken their company to new heights of innovation and growth across the globe.
«I am grateful for the high appreciation. It all became possible due to our team exceptional competency, business speed accomplishment and strong investors belief. As soon as we revealed the results of proof-of-concept study investor’s were convinced in the company’s potential. They invested $3.5 million in round A. The money raised was immediately used for further research and obtaining a patent and unprecedented for BC detections results. We had undertaken a series of extensive blinded studies on 1,160 patients in Russia and are preparing to launch clinical trials this spring in New Jersey and Manheim. We intend to finalize CE-Mark registration in Europe and LDT status from the FDA in the U.S.» — Egor says.
The full text of an interview: https://globalawards.ceotodaymagazine.com/winners-edition/122/
Next year I see as even filled with discoveries and public announcements. We are preparing a number of patents with special attention to ARNA-3 technology applicability for various diseases other than cancer. We are sure that as soon as published they will attract attention of the professional community and earn international recognition. Our vision is that we will need about 2 or 3 more investment rounds before we can be called as “Unicorn” with a valuation above $1 billion: $20 million in 2 years and another $85 million in 4. We do trust in what we do and “ARNA – way”